StockData
Precipio, Inc. logo

Precipio, Inc. (PRPO) stock analysis

PRPONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$23.25−1.55 (-6.25%)

Close on Nov 12, 2026Market cap $41.62MP/E –Yield –

StockData Score

Prices as of Nov 12, 2026How the score works

Value1Growth2Performance0Health2Dividend0

Weak5 of 30 checks passed

Precipio passes 5 of the 30 checks behind our score; 21 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
1/6
Growth
2/6
Past performance
0/6
Financial health
2/6
Dividend
0/6

What stands out

  • Revenue growing 10%+ a year

    Revenue grew 36.7% a year over the last three fiscal years.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 490% of total debt.

  • P/S below the industry

    Precipio's price-to-sales of 1.50 is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 3.81 (book value is negative, so we use sales).

  • Growing faster than the industry

    Revenue grew 21.8% over the last twelve months; the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median is 8.0%.

What to watch

  • Elevated bankruptcy risk

    The Altman Z-score is -1.87; above 3 is the safe zone and below 1.8 the distress zone.

  • Gross margin slipping

    Gross margin was 44.6% over the last twelve months, against 44.8% a year earlier.

  • Net margin below the industry

    Precipio's net margin of -4.1% is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of -3.5%.

  • No dividend

    Precipio has not paid a dividend in the last twelve months.

Valuation1/6

  • P/E against its history

    Not enough price and earnings history to compare.

  • P/E against the industry

    Needs positive earnings and enough profitable companies in the industry.

  • EV/EBITDA against its history

    Needs positive EBITDA and price history.

  • P/S below the industry

    Precipio's price-to-sales of 1.50 is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 3.81 (book value is negative, so we use sales).

  • Price against fair value

    We could not estimate a fair value: it needs at least two valuation methods with positive inputs.

  • Margin of safety

    Depends on the fair value estimate.

Growth2/6

  • Revenue growing 10%+ a year

    Revenue grew 36.7% a year over the last three fiscal years.

  • EPS growth over 3 years

    Needs positive EPS three years ago and today.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing faster than the industry

    Revenue grew 21.8% over the last twelve months; the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median is 8.0%.

  • Company guidance

    No outlook found in earnings releases from the last twelve months.

  • Gross margin slipping

    Gross margin was 44.6% over the last twelve months, against 44.8% a year earlier.

Past performance0/6

  • Return on equity

    Needs positive equity and five years of results.

  • Return on invested capital

    Needs operating income and invested capital.

  • Return on equity against the industry

    Needs positive equity.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin against its history

    Needs five years of revenue and net income.

  • Net margin below the industry

    Precipio's net margin of -4.1% is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of -3.5%.

Financial health2/6

  • Debt level

    Needs debt and equity figures.

  • Debt trend

    Needs a balance sheet from five years ago with positive equity.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 490% of total debt.

  • Interest coverage

    Interest expense is not reported separately.

  • Short-term assets cover short-term debts

    Current assets are 1.77 times current liabilities.

  • Elevated bankruptcy risk

    The Altman Z-score is -1.87; above 3 is the safe zone and below 1.8 the distress zone.

Dividend0/6

  • No dividend

    Precipio has not paid a dividend in the last twelve months.

  • Yield against Treasuries

    No dividend.

  • Yield against the market

    No dividend.

  • Dividend stability

    No dividend.

  • Earnings cover

    No dividend.

  • Cash-flow cover

    No dividend.

Scores of similar companies

Fair value

How we estimate it

We don't publish a fair value for Precipio. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/B at month end
  • Own 5-year median 0.9
  • Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median 3.2

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

High risk

Average value traded per day
$750.30K
Value traded per 1% price move
$226.67K

Downside

Medium risk

Typical loss in a bad month
24.4%
Volatility (annualized)
65%
Sharpe ratio, 1 year
0.16
Beta to the S&P 500 (5Y)
0.78

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Gross margin

44.5%+25.6 pts over 5 years

Operating margin

-5.0%+145.1 pts over 5 years

Net margin

-1.5%

See a number that looks wrong?